Integrating palliative medicine into an oncology practice

Abstract

Get full access to this article

View all access options for this article.

References

World Health Organization : Cancer Pain Relief and Palliative Care. Technical Report Series 804, Geneva, Switzerland, 1990.

Cairns W : The problem of definitions. Prog Pall Care. 2001; 9(5): 187-189.

Saunders C : The evolution of palliative care. Patient Educ Couns. 2000, 41:7-13.

Donnelly S , Walsh D : The symptoms of advanced cancer. Semin Oncol. 1995; 22(2): 67-72.

Homes J , Walsh D , Nelson KA , et al. : The impact of a palliative medicine consultation service in medical oncology. Support Care Cancer. 2001; 10(4): 1-11.

Reuben DB , Moor V , Hires J : Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med. 1988; 148(7): 1586-1591.

Miltonic M , Proven M , Nanny O , et al. : Biological indices predictive of survival in 519 Italian terminally ill cancer patients. J Pain Symptom Manage. 1997; 13(1): 1-9.

Cleeland CS , Mendoza TR , Wang XS , et al. : Assessing symptom distress in cancer patients. The MD Anderson Symptom Inventory. Cancer. 2000; 89(7): 1634-1646.

Waller A , Carolyn N (eds.): Handbook of Palliative Care in Cancer (2nd ed.). Woburn, MA: Butterworth-Heinemann, 2000.

10.

Faull C , Carter Y , Woolf R (eds.): Handbook of Palliative Care. Oxford, UK: Blackwell Science Ltd., 1998.

11.

Twycross R (ed.): Symptom Management in Advanced Cancer (2nd ed.) Oxon, UK: Radcliff Medical Press, 1997.

12.

Woodruff R : Palliative Medicine: Symptomatic and Supportive Care for Patients with Advanced Cancer and AIDS (2nd ed.). Victoria, AU: Asperula Pty Ltd, 1996.

13.

Walsh D , Doona M , Molnar M , et al. : Symptom control in advanced cancer: Important drugs and routes of administration. Semin Oncol. 2000; 27(1): 69-83.

14.

Ellison NM : Palliative chemotherapy. In Berger A , Portenoy R , Weissman DE (eds.): Principles and Practice of Supportive Oncology. Philadelphia: Lippincott-Raven, 1998: pp. 667-669.

15.

Ellison NM : Palliative chemotherapy. Am J Hosp Palliat Care. 1998; 15(2): 93-103.

16.

Archer VR , Billingham LJ , Cullen MH : Palliative chemotherapy: No longer a contradiction in terms. Oncologist. 1999; 4(6): 470-477.

17.

Mead GM : Chemotherapy for solid tumours. Routine treatment not yet justified. BMJ. 1995; 310(6974): 246-247.

18.

Ahmedzai SH , Walsh D : Palliative medicine and modern cancer care. Semin Oncol. 2000; 27(1): 1-6.

19.

Detmar SB , Muller MJ , Schornagel JH , et al. : Role of health-related quality of life in palliative chemotherapy treatment decisions. J Clin Oncol. 2002; 20(4): 1056-1062.

20.

Gianmauro N , Russi E , Merlano M : Best supportive care in non-small cell lung cancer: Is there a role for radiotherapy and chemotherapy? Lung Cancer. 2001; 32: 213-226.

21.

Doyle C , Crump M , Pintilie M , et al. : Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol. 2001; 19(5): 1266-1274.

22.

Donnelly S , Rybicki L , Walsh D : Quality of life measurement in the palliative management of advanced cancer. Support Care Cancer. 2001; 9(5): 361-365.

23.

Coates A : Quality of life and supportive care. Support Care Cancer. 1997; 5(6): 435-438.

24.

Cella DF : Methods and problems in measuring quality of life. Support Care Cancer. 1995; 3(1): 11-22.

25.

Feld R : Endpoints in cancer clinical trials: Is there a need for measuring quality of life? Support Care Cancer. 1995; 3(1): 23-27.

26.

Jassem J , Krzakowski M , Roszkowski K , et al. : A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: Clinical outcomes and quality of life. Lung Cancer. 2002; 35(1): 73-79.

27.

The Elderly Lung Cancer Vinorelbine Italian Study Group : Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst. 1999; 91(1): 66-72.

28.

Bonomi PD , Finkelstein DM , Ruckdeschel JC , et al. : Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol. 1989; 7(11): 1602-1613.

29.

Thatcher N , Anderson H , Betticher DC , et al. : Symptomatic relief from gemcitabine and other chemotherapy in non-small cell lung cancer: Changes in performance and cancer related symptoms. Anticancer Drugs. 1995; 6(suppl6): 39-48.

30.

Tannock IF , Osoba D , Stockler MR , et al. : Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol. 1996; 14(6): 1756-1764.

31.

Moore MJ , Osoba D , Murphy K , et al. : Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. J Clin Oncol. 1994; 12(4): 689-694.

32.

Glimelius B , Hoffman K , Graf W , et al. : Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol. 1995; 6(3): 267-274.

33.

Socinski MA , Schnell MJ , Peterman A , et al. : Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. J Clin Oncol. 2002; 20(5): 1335-1343.

34.

Schaafsma J , Coy P : Response of global quality of life to high-dose palliative radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biophys. 2000; 47(3): 691-701.

35.

Whippen DA , Canellos GP : Burnout syndrome in the practice of oncology: Results of a random survey of 1,000 oncologists. J Clin Oncol. 1991; 9(10): 1916-1920.

36.

Vachon MLS : Stress and burnout in oncology. In Berger A , Portenoy R , Weissman DE (eds.): Principles and Practice of Supportive Oncology. Philadelphia: Lippincott-Raven, 1998: pp. 833-843.

37.

Bruera E , Neumann C : Respective limits of palliative care and oncology in the supportive care of cancer patients. Support Care Cancer. 1999; 7(5): 321-327.

38.

Maltoni M , Amadori D : Palliative medicine and medical oncology. Ann Oncol.12(4): 443-450.

39.

Dumont I , Dumont S , Turgeon J : Continuity of care for advanced cancer patients. J Palliat Care. 2005; 21(1): 49-56.

40.

Von Roenn JH , Cleeland CS , Gonin R , et al. : Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993; 119(2): 121-126.

41.

Porzio G , Valenti M , Aielli F , et al. : Assessment and treatment of symptoms among Italian medical oncologists. Support Care Cancer. 2005; Apr 29 [E-pub ahead of print].

42.

Goldstein P , Walsh D , Horvitz L : The Cleveland Clinic Foundation Harry R. Horvitz Palliative Care Center. Support Care Cancer. 1996, 4(5): 329-333.

43.

Tropiano P , Walsh D : Organization of services and nursing care: Hospice and palliative medicine. Semin Oncol. 2000; 27(1): 7-13.

44.

Walsh D : The Harry R. Horvitz Center for Palliative Medicine (1987-1999): Development of a novel comprehension integrated program. Am J Hosp Palliat Care. 2001; 18(4): 239-250.

45.

DeConno F , Ripamonti C , Caraceni A , et al. : Palliative care at the National Cancer Institute of Milan. Support Care Cancer. 2001; 9(3): 141-147.

46.

Kloke M , Scheidt H : Pain and symptom control for cancer patients at the University Hospital in Essen: Integration of specialists’ knowledge into routine work. Support Care Cancer. 1996; 4(6): 440-447.

47.

Berger A , Baker K , Bolle J , et al. : Establishing a palliative care program in a research center: Evolution of a model. Cancer Invest. 2003; 21(2): 313-320.